Back to search

Georgia Institute of Technology

Culture systems for controlling mesenchymal stromal cell, protein, and cell-secreted protein release

Abstract

dc:description.abstract

Mesenchymal stromal cells (MSCs) are highly-secretory cells that are of great clinical interest, due to their immunomodulatory and pro-regenerative properties when transplanted in vivo. Despite their clinical potential, current methods commonly used for MSC culture are unsuitable for their production as secretory cell therapies at clinical- or commercial scales. Furthermore, their development has been limited by a poor understanding of mechanisms regulating MSC secretory and therapeutic function. Comprehensive investigation of different conditioning strategies and culture systems is needed to identify those critical to improving the production of MSCs and MSC-secreted factors. Doing so may also reveal key cellular processes controlling therapeutic factor release, which may be further leveraged to improve MSC potency. The long-term goal of this thesis was to develop culture systems for better understanding and controlling the release of cells, proteins, and cell-secreted proteins towards improved MSC scaling and, ultimately, potency as a therapeutic product. First, multiomics characterization of MSCs cultured in monolayer and as aggregates was performed to evaluate changes to cell physiology corresponding with enhanced secretory activity. Additionally, MSCs were cultured on hydrogel substrates with different mechanical and biochemical properties to determine those most important for controlling MSC proliferation and secretion. Next, one critical culture substrate property (stiffness) was utilized to develop microcarriers for improving secretion by genetically-modified MSCs. Lastly, a novel culture substrate responsive to Factor Xa was developed for on-demand release of MSCs from culture, as well as for the release of proteins for therapeutic applications. Overall, this work provides strategies for better interrogating and improving MSC bioactive factor release, which may be used to further develop highly efficacious MSC-based therapies, as well as other therapies that rely on responsive release of bioactive agents.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Biomedical Engineering (Joint GT/Emory Department)
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Doron, Gilad
Advisors dc:contributor.advisor
  • Temenoff, Johnna S.
  • Guldberg, Robert E.
Committee members dc:contributor.committeemember
  • Willett, Nick
  • Wood, Levi
  • Evans, Christopher H.

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/72443

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Doron, Gilad. Culture systems for controlling mesenchymal stromal cell, protein, and cell-secreted protein release. Doctoral thesis, Georgia Institute of Technology, 2022. https://hdl.handle.net/1853/72443